← Back to patent-cliff list
CAS 1257519-35-9
(S)-3-(1-hydroxyethyl)phenyl ethyl(methyl)carbamate3-[(1S)-1-Hydroxyethyl]phenyl ethyl(methyl)carbamate
Codes: RIVAT-015, (II)145089-21-a
Application context (from source-drug indications)
Alzheimer's diseaseRivastigmine TartrateDementiaRivastigmine TartrateParkinson's diseaseRivastigmine Tartrate抗胆碱能综合征Rivastigmine Tartrate神经行为学表现Rivastigmine TartrateCognitive impairmentRivastigmine Tartrate
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Rivastigmine Tartrate | Tier B — Position early | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
ethyl(methyl)carbamic chloride→1-(3-hydroxyphenyl)ethan-1-one→3-acetylphenyl ethyl(methyl)carbamate→(S)-3-(1-hydroxyethyl)phenyl ethyl(methyl)carbamate→(R)-3-(1-bromoethyl)phenyl ethyl(methyl)carbamate
3-Acetylphenyl ethyl(methyl)carbamate→3-[(1S)-1-Hydroxyethyl]phenyl ethyl(methyl)carbamate→Dimethylamine anhydrous→(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate→3-[(1R)-1-Hydroxyethyl]phenyl ethyl(methyl)carbamate
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.